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Abstract: Aim: The present study aimed to assess the clinical efficacy of 
nanosilver (NS) mouthwash and compared with chlorhexidine (CHX) 
mouthwash for the treatment of plaque-induced gingivitis. Materials and 
methods: Sixty-two (28 males and 34 females) plaque-induced gingivitis 
patients were allocated into two groups and asked to rinse with 10ml of NS 
or CHX, immediately after brushing, for 1 min, in the morning and evening. 
The plaque, gingival, and papilla bleeding indices were taken at baseline, 
two weeks, and finally at four weeks for each patient. The statistical analysis 
between and within groups were performed using Mann-Whitney U-test and 
Wilcoxon signed rank test respectively. Result: Intergroup comparison by 
Mann-Whitney U-test showed no statistically significant differences in the 
investigated groups at the baseline for all studied parameters. At 2 and 4 weeks 
follow up, the CHX group showed statistically significant lower plaque scores 
than the NS group (p<0.05). However, there is no statistically significant 
difference between NS and CHX groups for gingival and papilla bleeding scores 
(p>0.05). Both groups showed statistically significant reductions in plaque, 
gingival and papilla bleeding scores after 2 weeks and 4 weeks of product 
use when compared to baseline (p<0.001). Conclusion: Both mouthwashes 
decreased plaque, gingival and papilla bleeding scores, however the reduction 
in plaque scores was higher for the CHX group compared to the NS group. 
Keywords: Dental plaque; gingivitis; antimicrobial mouthwash; nanosilver; 
chlorhexidine.
INTRODUCTION.
The oral cavity represents an environment for the coloniza¬tion and 
growth of many microorganisms, particularly bacteria.1 There are more 
than 600 bacterial species that colonize the mouth at a concentration of 
108–109 bacteria per ml of saliva or mg of dental plaque.2 
It is widely accepted in dentistry that dental plaque is a key etiological 
factor that causes gingivitis and initiates periodontal disease.3 Dental 
plaque is a dynamic complex oral biofilm consisting of bacterial toxin 
and carbohydrate matrices which adhere to each other and to dental 
surfaces.4 Destruction of the gingival tissues is caused by interaction of 
a inflammatory process in the periodontal tissue and microorganisms in 
the dental plaque.5 
The main objective of periodontal management is to establish 
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adequate infection control through disruption of the 
biofilm and suppression of the inflammation. Mechanical 
plaque control is considered the cornerstone of plaque 
treatment.6 However, mechanical plaque control requires 
motivation and skills. Therefore, chemical plaque control 
is required to overcome the insufficiency of mechanical 
plaque control. Consequently, antimicrobial agents have 
been used as adjuncts to daily oral care in the control of 
plaque and gingivitis.7
There are several types of antimicrobial agents 
available in the market today worldwide such as enzymes, 
bisbiguanides, phenolic compounds, quaternary ammo-
nium compounds, Listerine®, cetylpyridinium chloride, 
delmopinol hydrochloride, triclosan, acidified sodium 
chlorate, salifluor, oxygenating agents, essential oils, 
fluoride, peroxide and chlorhexidine (CHX).8 Ideally, it is 
required that any antimicrobial agent used should able to 
modify the oral environment by being precisely effective 
against pathogens without altering the normal flora. 
CHX in the form of a mouthwash, varnish or dentifrice 
gel is the most broadly used and has yielded beneficial 
results as a preventive strategy. CHX mouthwash has 
been the agent of choice as an antiplaque agent and is 
considered as the gold standard.8 Nevertheless, despite 
its effectiveness in reducing the levels of microorganisms 
in the oral cavity, long-term use of CHX products is 
associated with local side effects such as tooth staining, 
impaired sense of taste on dorsum of tongue, increased 
formation of supragingival calculus, occasional irritation 
and desquamation of mucous membranes and bitter 
taste.8,9 Thus, its acceptance by patients can be limited 
due to its side effects, particularly when a longer period of 
use is recommended. To overcome these side effects, the 
researchers continue searching for anti-plaque agents with 
less or free of side effects on gingival and gum tissues. 
Nanotechnology is the science which deals with the 
production of functional materials and structures in the 
nanoscale using various physical and chemical methods. 
Nanosilver (NS) mouthwash was introduced into the 
market and preferred due to small size properties in 
antibacterial activity as surface area of nanoparticles 
size allow for more contact with the bacterial cells. This 
is due to the capability of nanoparticles to penetrate 
bacteria and other microorganisms and destroy them. 
NS mouthwash has shown potent anti-plaque and anti-
gingivitis activity.10  
Some authors have reported that the nanosilver has 
higher antimicrobial effect than chlorhexidine,10,11 
however other investigators found that the antimicrobial 
effect of nanosilver was lower than chlorhexidine.12-14 
Therefore, there is no agreement on the ideal mouthwash 
with excellent antimicrobial effects. Furthermore, nano-
silver mouthwash has not yet been investigated clinically, 
and information is lacking as to when and how to use 
these agents for maximum benefit. As such, practitioner 
decision regarding the selection of the proper mouthwash 
is made difficult by the number of existing options. 
Therefore, the current study was carried out, which 
aimed to assess the clinical efficacy of a NS mouthwash 
compared with a CHX mouthwash as the treatment of 
plaque-induced gingivitis.
The null hypothesis was that there is no difference 
between NS and CHX mouthwashes in the clinical 
efficacy of treatment of plaque-induced gingivitis. 
MATERIALS AND METHODS.
Study Design
This study was a triple-blinded randomized controlled 
comparative trial of four weeks duration, conducted in the 
Dental Polyclinics of the Dental College at University of 
Science and Technology (UST), Sana´ a, Yemen. The trial 
was registered and allocated at the ACTRN (the number 
in ANZCTR: ACTRN12618001265268).
Bioethical considerations
All patients signed an informed consent form. Ethical 
approval was obtained from the Faculty of Medicine and 
Health Sciences at UST (MECA No. 2016/22). 
Study Population
The sample of the present study consisted of patients 
with an average age of 23 years referred for treatment to 
the Dental Polyclinics of the Dental College at UST. The 
subjects were enrolled between January and November 
2017. The inclusion criteria comprised good general health, 
availability for the 4 weeks of study duration, evidence 
of plaque-induced gingivitis without periodontitis, and 
a minimum of 20 natural teeth, excluding third molars. 
Subjects were excluded from the study if they had any 
of the following conditions: orthodontic bands; partial 
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removable dentures; were pregnant or breast feeding; 
systemic disorders or on medications that might influence 
the periodontium; a history of allergy to oral consumer 
products; who smoked; periodontal treatment or antibiotic 
therapy any time during the previous month; tumor(s) or a 
significant pathology in the soft or hard tissues of the oral 
cavity; five or more carious lesions needing immediate care; 
subjects who had received dental prophylaxis in the two 
weeks prior to the baseline examination. 
Participants were randomly selected using the fishbowl 
technique (with or without replacement), in which 
any subject who enters to the dental polyclinics of the 
dental college at the UST was selected after a screening 
examination, and chosen according to the inclusion/
exclusion criteria. The UST was selected as it is oldest 
university in Yemen and its service offered in the dental 
polyclinics attracts many patients who can get access to 
free dental care. Those patients come from Sana’a city and 
its surrounding neighborhoods. This city is the largest 
in Yemen, with a population of about 3 million people. 
Moreover, the majority of the residents are migrants from 
all over the country.
After a screening examination that included a full 
medical and dental history and intraoral examination, 
the final sample size in the study consisted of 68 patients 
with plaque-induced gingivitis according to the inclusion/
exclusion criteria. 
The subjects were then randomly divided into two 
groups as shown in Figure 1:
The control group that consisted of 34 patients who 
rinsed with 0.12% chlorhexidine mouthwash (Shiba 
Pharma co., Yemen), 10ml for one minute twice daily. The 
experimental group included 34 patients who rinsed with 
a nanosilver mouthwash (Nanogist co., Korea), 10 ml for 
one minute twice daily.
Experimental Design
All patients received a complete dental prophylaxis 
to remove all plaque, calculus and extrinsic stain before 
entering the study.15 The participants were motivated on 
regular intervals by personal and phone contact, to use 
tooth brush and mouthwash on regular basis. The patients 
were instructed to use a soft tooth brush, brush only with 
the same toothpaste (Colgate® Cavity Protection fluoride 
toothpaste) and to brush their teeth twice daily, once in 
the morning after breakfast and once in the evening before 
bedtime, for a minimum of three minutes. They also were 
instructed on the Bass brushing technique, and to rinse 
their mouth with mouth wash at least half an hour after 
tooth brushing and not to ingest any liquid or food for 
at least 30 minutes afterwards, to avoid decreasing the 
efficacy of the mouth wash, and to diminish the side effects 
of CHX like staining and bad taste.8
All mouth rinses were packaged by an assistant in opaque 
bottles containing the codes A and B. The assistant added 
a new patient to a list of randomly assigned letters (A and 
B), and the patient was given the medication assigned that 
letter. Thus, this way the triple blinding of the examiner 
(AA), the supervisor (WA) and the subjects was achieved.
In the present study six teeth were chosen, which 
represent the six segments of the jaw as proposed in Löe 
and Silness.16 Thus the clinical parameters were assessed 
in the following selected teeth (maxillary right 1st 
molar, maxillary right lateral incisor, maxillary 1st first 
bicuspid, mandibular left 1st molar, mandibular left lateral 
incisor and mandibular right 1st bicuspid).12 The clinical 
parameters (plaque, gingival, papilla bleeding indices) were 
taken at baseline, two weeks, and finally at four weeks for 
each patient. Indices were measured from four surfaces for 
each index tooth, then the mean value was calculated for 
each tooth and finally for each participant. The calibration 
performed for this step resulted in high intra-examiner 
agreement. (Kappa =0.90)
Statistical Analysis  
The analysis of the data was performed using SPSS 
21.0 for Windows (SPSS Inc., Chicago, IL, USA). The 
Mann-Whitney U-test was used to determine statistical 
significance between groups (intergroup analysis). The 
clinical parameters within the groups were evaluated using 
the Wilcoxon signed rank test (intragroup analysis). The 
significance level was set at p< 0.05.
RESULTS.
At the onset of the study, there were 68 participants. 
Six participants dropped out, 2 from NS group, and 
4 from CHX group, thus at the end of the study, 62 
participants were present (CHX=30, and NS=32). 
Dropping out was due to failure in following the study 
protocol. 
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Figure 1. Study design flowchart showing participants' studied parameters, allocation, follow-up, and analysis.
Table 1. Means (SD) and medians of studied clinical parameters on baseline, second and third visits for treatment groups.
M = Mean. SD = Standard deviation.
a. Intergroup analysis showed significant differences between groups in two weeks and four weeks for plaque index score (p< 0.05). However other clinical 
parameters did not show significant differences between NS and CHX (p >0.05).
b. Intragroup analysis showed significant differences within the groups from baseline to 3rd visits (at 4 weeks), from baseline to 2nd visits (at two weeks), and from 
2nd to 3rd visits for clinical parameters (p< 0. 001).
Selectionof study sample according to inclusion/exclusion criteria
(n =68)
Study sample
(n =68)
Study parameters
1. Plaque score
2. Gingival score
3. Papila bleeding score
At the end of follow up
(Drop our=2) 
At the end of follow up 
(Drop our=4) 
between CHX ( n = 34) 
and CHX (N =30).
Allocation to intervention
Data collected tabulated and analyzed
NS (n =34)
(Male 17,  Female 17)
NS (n =32)
(Male 15,  Female 17)
CHX (n =34)
(Male 17,  Female 17)
CHX (n =30)
(Male 14,  Female 17)
 Papilla bleeding scores
 Baseline Two week Four week 
 M±SD Median M±SD Median M±SD Median
NS  2.39± 0.48 2.50 0.86±0.43 0.91 0.39± 0.28 0.33
CHX  2.47± 0.28 2.54 0.89±0.41 0.83 0.42± 0.32 0.29
 Gingival index scores 
 Baseline Two week Four week 
 M±SD Median M±SD Median M±SD Median
NS  1.92± 0.16 1.95 1.16± 0.31 1.12 0.74± 0.30 0.75
CHX  1.90± 0.09 1.91 1.23± 0.31 1.25 0.76± 0.29 0.75
 Plaque index score 
 Baseline Two week Four week 
 M±SD Median M±SD Median M±SD Median
NS  1.51± 0.39 1.58 0.70± 0.31 0.63 0.55± 0.26 0.54
CHX  1.51± 0.41 1.62 0.39± 0.14 0.37 0.25± 0.14 0.25
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The mean (SD) and median values of plaque, gingival, 
and papilla bleeding scores of both NS and CHX groups 
are shown in Table 1. Intergroup comparison by Mann-
Whitney U-test showed no statistically significant 
differences between the groups at baseline for all studied 
parameters. At two and four weeks follow up, the CHX 
group showed statistically significant lower plaque scores 
compared to the NS group (p<0.05). However, there is 
no statistically significant difference between NS and 
CHX groups for gingival and papilla bleeding scores at 
2 and 4 weeks follow up as shown in Table 1. When 
the amount of reduction in plaque scores was compared, 
the CHX group showed a significant reduction in 
plaque scores compared to the NS group from baseline 
to 2 and four weeks of product use (p<0.05). However 
there was no statistical significant difference on the 
amount of plaque, gingival and papilla bleeding scores 
reduction from two to four weeks between the NS and 
CHX groups (p>0.05). Also, there was no statistically 
significant difference between both groups regarding 
the amount of reduction in gingival and papilla bleeding 
from baseline to two and four weeks (p>0.05).
Intragroup comparison by Wilcoxon signed rank test 
showed a statistically significant reductions in plaque, 
gingival and papilla bleeding scores after two and four 
weeks of product use when compared to baseline (p<0. 001) 
as shown in Table 1. Also there a statistically significant 
reduction (p<0.001) in plaque, gingival, papilla and 
bleeding scores for both mouthwash groups (NS, and 
CHX) comparing two and fo r weeks of product use. 
DISCUSSION.
Dental plaque has long been considered to be the main 
etiological agent in gingivitis, and periodontal disease. 
Therefore, suitable plaque control is vital to prevent the 
incidence of the aforementioned conditions.17 Plaque 
control can be accomplished by mechanical or chemical 
means, or by a combination of both. Mouthwash is a 
chemical plaque control that should be used alongside 
mechanical hygiene.12,18 It has been recommended as a 
regular adjunct to mechanical therapy to maintain oral 
health.19
CHX has ben used for many years as part of a 
periodontal treatment regimen and is considered the gold 
standard.8 However, CHX is known to have various side 
effects,8,9,20  therefore its use as long-term therapy has been 
limited or not actively recommended.20 Considering the 
drawbacks of CHX mouthwash, alternative antiplaque 
agents have been developed in the recent years. These 
alternative antiplaque agents do not the same negative 
effects of CHX, but none has been successful in providing 
similar antiplaque and anti-gingivitis effect.8,9,20 In 
recent time, NS mouthwash has gained attention for its 
antimicrobial properties.21 This is due to the smaller size of 
these particles  (nanoparticles), which have the potential 
to penetrate and kill microorganisms. Thus, the present 
study was conducted to compare the effects of NS and 
CHX on the treatment of patients with plaque-induced 
gingivitis using clinical parameters.
Assessment of the gingival health was determined 
using three indices. Plaque index (PLI) is the most 
sensitive indicator for dental deposits. Papilla bleeding 
index (PBI) is the most sensitive indicator for gingival 
health, marginal periodontitis and interproximal alveolar 
bone loss and the effectiveness of preventive procedures 
is more easily related to the presence or absence of 
interdental plaque. Gingival index (GI) is one of the most 
commonly used indices for assessing the gingival health 
status. A combination of these indices provides a reliable 
assessment for superiority or equivalence of antiplaque 
and antiseptic agents.12,15,18,22
In this study, there was no significant difference 
between the baseline data of both groups. Generally, 
both groups showed a highly significant reduction in 
PLI, GI and BPI at two and four weeks. There was no 
statistical difference between both groups, except that 
CHX demonstrated more reduction in mean PLI with a 
significant difference compared to NS. The findings of 
the present study are consistent with previous studies.22-27 
Jain et al.,22 noticed that there was a significant decrease in 
plaque score in CHX group at 15 days and 30 days. In this 
study, a significant reduction in PLI, GI and BPI at two 
and four weeks was found after using CHX mouthwash. 
The findings of the current study concur with those of 
Chandrasekaran et al.,15 who showed that rinsing with 
CHX caused a significant decrease in the mean of PLI 
and GI at the 3rd follow-up visit. The results of this study 
are also in agreement with a study conducted by Halkai 
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et al.,24 who reported NS antibacterial activity against 
Porphyromonas gingivalis Shawky et al.,25 showed that 
NS resulted in a pronounced improvement in clinical 
parameters and reduction of microbial infections. Lu 
et al.,26 showed that NS had apparent antibacterial 
effects against five anaerobic oral pathogenic bacteria 
and aerobic bacteria. Freire et al.,27 also showed that NS 
significantly reduced the CFUs four fold in 24 hours. 
Sadeghi et al.,28 reported that NS had bactericidal effects 
against Streptococcus mutans comparable to CHX.
In contradiction to the current study Esfahanian 
et al.,12 showed that CHX mouthwash had a significant 
statistical superiority to NS mouthwash. Differences in 
results could be due to differences in the composition 
of the NS (hydrogen peroxide formulation that contains 
few silver ions), a different concentration of CHX (0.2%) 
and also due to differences in methodology. The present 
study were used the mouth wash as irrigation in the 
mouth in vivo not in an in vitro laboratory setting, 
and presence of the biofilm in the mouth may cause 
differences in the results.
Besinis et al.,11 showed that NS had the strongest 
antibacterial activity of all tested nanoparticles, with 
bacterial growth lower than that in the CHX group. 
Mozayeni et al.,13 indicated that NS gel had lower activity 
against Candida albicans than CHX gel. Disagreement 
with the results of this study may be attributed to 
differences in product formulation and the targets of 
study, as they focused on antifungal activity.
There are some limitations of this study that should 
be considered. The number of plaque-induced gingivitis 
studied was limited; further study with a larger sample 
number should be performed to confirm the results. 
Moreover, this study was performed in young patients, 
and the microbiota in adult patients may differ and could 
yield different results in other populations. In addition, 
no objective sample calculation was performed. Also, 
the samples were not objectively randomized according 
to Consort 2010. Lastly, the follow-up period was only 
four weeks; further studies with a longer follow-up 
period should be considered.
CONCLUSION.
Within the limitations of the present study, it can be 
concluded that the NS mouthwash was comparable to the 
CHX mouthwash in reducing plaque, gingival and papilla 
bleeding scores, however CHX was better in decreasing 
plaque scores than NS. 
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